Difference between revisions of "Christian Drosten"
(Tidy and job fix. Note use of "|employer" to allow the title to be more generic) |
(fixes) |
||
| Line 1: | Line 1: | ||
{{person | {{person | ||
|wikipedia=https://en.wikipedia.org/w/index.php?title=Christian_Drosten | |wikipedia=https://en.wikipedia.org/w/index.php?title=Christian_Drosten | ||
| − | | | + | |description=Germany's "real face of the coronavirus crisis", Big pharma |
|image=Drosten Charite 3c4779e817.jpg | |image=Drosten Charite 3c4779e817.jpg | ||
|nationality=German | |nationality=German | ||
| Line 12: | Line 12: | ||
|wikiquote= | |wikiquote= | ||
|spouses= | |spouses= | ||
| − | |alma_mater=University Frankfurt am Main | + | |alma_mater=University of Frankfurt am Main |
|birth_name=Christian Heinrich Maria Drosten | |birth_name=Christian Heinrich Maria Drosten | ||
|political_parties= | |political_parties= | ||
| Line 29: | Line 29: | ||
}} | }} | ||
}} | }} | ||
| − | '''Dr Christian Drosten''' is a German [[virologist]] whose research focus is on novel viruses ''(emergent viruses)''. During the [[ | + | '''Dr Christian Heinrich Maria Drosten''' is a German [[virologist]] whose research focus is on novel viruses ''(emergent viruses)''. During the [[Covid-19 pandemic]], Drosten came to national prominence as an expert on the implications and actions required to combat the outbreak in [[Germany]].<ref name="Henley_2020"> |
https://www.theguardian.com/world/2020/mar/22/coronavirus-meet-the-scientists-who-are-now-household-names | https://www.theguardian.com/world/2020/mar/22/coronavirus-meet-the-scientists-who-are-now-household-names | ||
</ref> | </ref> | ||
Revision as of 07:32, 28 April 2020
 Christian Drosten    (Epidemiologist, Pharma lobbyist) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 | |||||||||||||||||||||||||
| Born | Christian Heinrich Maria Drosten 1972 | ||||||||||||||||||||||||
| Nationality | German | ||||||||||||||||||||||||
| Alma mater | University of Frankfurt am Main | ||||||||||||||||||||||||
| Member of | Robert Koch Institute | ||||||||||||||||||||||||
| Interest of | Corona Investigative Committee, Viviane Fischer, Reiner Fuellmich | ||||||||||||||||||||||||
Germany's "real face of the coronavirus crisis", Big pharma
| |||||||||||||||||||||||||
Dr Christian Heinrich Maria Drosten is a German virologist whose research focus is on novel viruses (emergent viruses). During the Covid-19 pandemic, Drosten came to national prominence as an expert on the implications and actions required to combat the outbreak in Germany.[1] The commercially-controlled media response in Germany was massively dominated by his changing opinions on how dangerous SARS-COV-2 'really' is.
Contents
"Corona-explainer-in-chief"
During the 2019–2020 coronavirus pandemic, Drosten was called by The Guardian as "the [German] country's real face of the coronavirus crisis", who also noted that the Süddeutsche Zeitung had described Drosten as "the nation's corona-explainer-in-chief".[1] He was a counterpart to Lothar Wieler, head of the State's Robert Koch Institute in Berlin, in consulting to German federal and state authorities.[1]
Research
Drosten is one of the co-discoverers of SARS-associated coronavirus (SARS-COV-1) in 2009.
Funding
In 2004, Drosten received the GlaxoSmithKline funding award.[citation needed]
Mixed messages
Concerning SARS-COV-2 he said that antibodies may develop naturally[citation needed]. On the other hand he shuts down[clarification needed] colleagues critical of the COVID-19/lockdown.[citation needed]
Profit
Drosten developed a test for SARS-COV-2, ready to be sold at 5x the normal price in January 2020, which was quickly accepted by the World Health Organization (WHO) who sent test kits to affected regions.[2]
Other activities
- World Health Summit 2020, Member of the Scientific Committee.[citation needed]
WP page of interest
References
Sponsor
| Event | Description |
|---|---|
| Bill & Melinda Gates Foundation | Very influential and rich foundation established to take leadership of global health. |
